PUBBLICAZIONI GISCAD
pagina 10
·
Sequential methotrexate and 5-fluorouracil as second-line chemotherapy for advanced colorectal cancer patients pretreated with
5-fluorouracil and leucovorin: a GISCAD study
Zaniboni A, Labianca R, Martignoni G, Barni S, Vinci M, Vaghi M, Pirovano M, Facendola G, Marini G, Luporini G.
J Chemother 1996; Feb 8 (1): 82-4
·
Efficacy of adjuvant fluorouracil and folinic acid in colon cancer
International Multicentre Pooled Analysis of Colon Cancer Trial. (IMPACT investigators).
Lancet, 1995; 345: 939-44
·
Epirubicin, cisplatin and continuous infusion 5-fluorouracil is an active and safe regimen for patients with advanced gastric cancer.
An Italian Group for the Study of Digestive Tract Cancer (GISCAD) report
Zaniboni A, Barni S, Labianca R, Marini G, Pancera G, Giaccon G, Piazza E, Signaroldi A, Legnani W, Luporini G.
Cancer 1995; Nov 15; 76(10): 1694-9
·
Oral etoposide as second-line chemotherapy for colorectal cancer: a GISCAD study. Gruppo Italiano Studio Carcinomi Apparato Digerente
Zaniboni A, Labianca R, Pancera G, Barni S, Frontini L, Marini G, Luporini G.
J Chemother 1995; Jul 7(3): 246-08
·
Double modulation of 5-fluorouracil in advanced colorectal cancer with low-dose interferon-alpha 2b and folinic acid.
The GIDCAD experience
Labianca R, Giaccon G, Barni S, Ambrosini G, Irillo A, Fiorentini G, Duro M, Piazza E, Oliani C, Pancera G, Cascinu S, Martignoni G, Zaniboni A, Dallavalle G, Luporini G and Italian Group for the Study of Digestive Tract Cancer
Eur J Cancer 1994; 30A (11): 1611-6
·
Preliminary report of an ongoing trial comparing surgery alone versus surgery and chemotherapy in operable gastric cancer.
Di Costanzo F, Gasperoni S, Labianca R, Sdrobolini A, Zamparelli G, Angiona S, Bartolucci R, Rossetti R.
J Chemother, 1996; 8 (suppl 4): 104-06
Biochimica modulation of fluoropyrimidines: the GISCAD studies. GISCAD (Italian Group for the Study of Digestive Tract Cancer)
·
Adv Exp Med Boil 1993; 339: 233-7
Labianca R, Pancera G, Barni S, Cascinu S, Comella G, Foa P, Martignoni G, Zaniboni A, Giaccon G, Luporini G.
Folinic acid + 5-fluorouracil (5-FU) versus equipoise 5-FU in advanced colorectal cancer. Phase III study of "GISCAD" (Italian Group for the Study of Digestive Tract Cancer)
·
Labianca R, Pancera G, Aitini E, Barni S, Beretta A, Beretta GD, Cesana B, Comella G, Cozzaglio L, Cristoni M, Spagnoli P, Frontini L, Gottardi O, Martignoni G, Scapaticci R, Smerieri F, Vinci M, Ladro A, Zaniboni A, Luporini G.
Ann Oncol. 1991, Oct 2 (9): 673-9